SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Ajanta Pharma
Ajanta Pharma
BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01049|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 09, 16:00
1300.95
1.55 (0.12%)
VOLUME 12,830
LIVE
NSE
Feb 09, 15:56
1297.95
-2.1 (-0.16%)
VOLUME 99,250
Download Annual Report PDF Format 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Ajanta Pharma

------------------- in Rs. Cr. -------------------
Dec '15 Sep '15 Jun '15 Mar '15 Dec '14
Net Sales/Income from operations 412.96 386.30 334.88 360.36 356.28
Other Operating Income 7.07 3.20 5.70 8.48 6.29
Total Income From Operations 420.03 389.50 340.58 368.84 362.57
EXPENDITURE
Consumption of Raw Materials 117.34 100.75 77.86 73.34 86.60
Purchase of Traded Goods 11.85 13.64 13.96 15.46 11.85
Increase/Decrease in Stocks -17.16 -8.11 2.30 14.53 1.87
Power & Fuel -- -- -- -- --
Employees Cost 58.47 58.83 54.55 50.81 48.17
Depreciation 11.12 10.31 9.70 12.59 12.59
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 100.31 96.84 82.10 73.98 82.67
P/L Before Other Inc. , Int., Excpt. Items & Tax 138.10 117.24 100.11 128.13 118.82
Other Income 4.20 23.04 13.53 2.84 6.27
P/L Before Int., Excpt. Items & Tax 142.30 140.28 113.64 130.97 125.09
Interest 1.31 0.93 1.03 1.05 1.20
P/L Before Exceptional Items & Tax 140.99 139.35 112.61 129.92 123.89
Exceptional Items -- -- -- -6.95 --
P/L Before Tax 140.99 139.35 112.61 122.97 123.89
Tax 37.65 44.98 31.55 38.66 39.18
P/L After Tax from Ordinary Activities 103.34 94.37 81.06 84.31 84.71
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 103.34 94.37 81.06 84.31 84.71
Equity Share Capital 17.69 17.69 17.69 17.68 17.68
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 11.74 10.73 9.21 9.59 24.08
Diluted EPS 11.74 10.72 9.21 9.58 24.06
EPS After Extra Ordinary
Basic EPS 11.74 10.73 9.21 9.59 24.08
Diluted EPS 11.74 10.72 9.21 9.58 24.06
Public Share Holding
No Of Shares (Crores) -- 2.31 2.31 2.30 0.92
Share Holding (%) -- 26.22 26.22 26.17 26.17
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- 0.27 0.10 0.11 0.11
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- 4.08 1.54 1.62 4.39
- Per. of shares (as a % of the total Share Cap. of the company) -- 3.01 1.14 1.20 3.24
b) Non-encumbered
- Number of shares (Crores) -- 6.23 6.39 6.39 2.48
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- 95.92 98.46 98.38 95.61
- Per. of shares (as a % of the total Share Cap. of the company) -- 70.77 72.64 72.63 70.59
Notes Notes To The Accounts
Source : Dion Global Solutions Limited
Quick Links for ajantapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.